Common errors in mass spectrometry‐based analysis of post‐translational modifications

MS Kim, J Zhong, A Pandey - Proteomics, 2016 - Wiley Online Library
Mass spectrometry (MS) is a powerful tool to analyze complex mixtures of proteins in a high‐
throughput fashion. Proteome analysis has already become a routine task in biomedical …

SHP-2 in lymphocytes' cytokine and inhibitory receptor signaling

C Niogret, W Birchmeier, G Guarda - Frontiers in immunology, 2019 - frontiersin.org
Somewhat counterintuitively, the tyrosine phosphatase SHP-2 (SH2 domain-containing
protein tyrosine phosphatase-2) is crucial for the activation of extracellular signal-regulated …

Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin

S Liu, M Verma, L Michalec, W Liu, A Sripada… - Journal of Allergy and …, 2018 - Elsevier
Background Type 2 innate lymphoid cells (ILC2s) represent an important type 2 immune
cell. Glucocorticoid regulation of human ILC2s is largely unknown. Objective We sought to …

Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia

SK Tasian, MY Doral, MJ Borowitz… - Blood, The Journal …, 2012 - ashpublications.org
Adults and children with high-risk CRLF2-rearranged acute lymphoblastic leukemia (ALL)
respond poorly to current cytotoxic chemotherapy and suffer unacceptably high rates of …

TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling

J Zhong, J Sharma, R Raju, SM Palapetta… - Database, 2014 - academic.oup.com
Thymic stromal lymphopoietin (TSLP) is a four-helix bundle cytokine that plays a critical role
in the regulation of immune responses and in the differentiation of hematopoietic cells. TSLP …

LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors

Y Cheng, K Chikwava, C Wu, H Zhang… - The Journal of …, 2016 - Am Soc Clin Investig
Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL) is a high-risk
ALL commonly associated with alterations that affect the tyrosine kinase pathway, tumor …

Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia

JW Bӧhm, KCS Sia, C Jones, K Evans, A Mariana… - Leukemia, 2021 - nature.com
Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a high-risk
ALL subtype with high rates of relapse and poor patient outcome. Activating mutations …

The coming of age of phosphoproteomics—from large data sets to inference of protein functions

PP Roux, P Thibault - Molecular & Cellular Proteomics, 2013 - ASBMB
Protein phosphorylation is one of the most common post-translational modifications used in
signal transduction to control cell growth, proliferation, and survival in response to both …

Effect of N-glycosylation on constitutive signal transduction by mutated cytokine receptor-like factor 2

R Yamamoto, R Segawa, J Liu, T Isaji, J Gu… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Background Cytokine receptor-like factor 2 (CRLF2) is a subunit of the receptor for thymic
stromal lymphopoietin (TSLP). A somatic mutation (insEIM) in the transmembrane domains …

Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL

C Hurtz, GB Wertheim, JP Loftus… - The Journal of …, 2020 - Am Soc Clin Investig
Children and adults with Philadelphia chromosome–like B cell acute lymphoblastic
leukemia (Ph-like B-ALL) experience high relapse rates despite best-available conventional …